TrialPloS one2021

Reperfusion After Fibrinolytic Therapy (RAFT): An open-label, multi-centre, randomised controlled trial of bivalirudin versus heparin in rescue percutaneous coronary intervention.

Amir Faour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.